As of 2:29pm ET
| -0.24 / -1.21%|
The 6 analysts offering 12-month price forecasts for Aegerion Pharmaceuticals Inc have a median target of 25.50, with a high estimate of 38.00 and a low estimate of 24.00. The median estimate represents a +30.23% increase from the last price of 19.58.
The current consensus among 7 polled investment analysts is to Hold stock in Aegerion Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.